论文部分内容阅读
目的探讨经尿道钬激光前列腺剜除术治疗良性前列腺增生的安全性和临床疗效。方法50例年龄超过70岁的高龄前列腺增生患者接受经尿道钬激光前列腺剜除术,术前及术后3个月进行国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、残余尿量(PVR)的测定。结果术前患者平均IPSS 29.9,QOL 5.3、Qmax7.2 ml/s、PVR 127.5 ml,术后3个月平均分别为9.7、1.9、16.3 ml/s、19.3 ml,均有显著性差异(P<0.05)。结论经尿道钬激光前列腺剜除术是一项安全、高效的治疗良性前列腺增生的新方法。
Objective To investigate the safety and clinical efficacy of transurethral holmium laser prostatectomy in the treatment of benign prostatic hyperplasia. Methods 50 elderly BPH patients over the age of 70 underwent transurethral holmium laser prostatectomy. The scores of IPSS, QOL, maximal uroflow rate (Qmax), residual urine volume (PVR) determination. Results The average preoperative IPSS 29.9, QOL 5.3, Qmax 7.2 ml / s and PVR 127.5 ml were 9.7,1.9,16.3 ml / s and 19.3 ml respectively at 3 months after operation (P < 0.05). Conclusion Transurethral holmium laser prostatectomy is a safe and effective new method for the treatment of benign prostatic hyperplasia.